RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Hansoh Pharmaceutical Group Company Stock

Hansoh Pharmaceutical Group Company Liabilities 2024

Hansoh Pharmaceutical Group Company Liabilities

7.24 B CNY

Ticker

3692.HK

ISIN

KYG549581067

WKN

A2PLRC

In 2024, Hansoh Pharmaceutical Group Company's total liabilities amounted to 7.24 B CNY, a -1.5% difference from the 7.35 B CNY total liabilities in the previous year.

Hansoh Pharmaceutical Group Company Aktienanalyse

What does Hansoh Pharmaceutical Group Company do?

The Hansoh Pharmaceutical Group Co Ltd is a leading company in the pharmaceutical industry in China. It was founded in 1995 and has its headquarters in Lianyungang, with branches in Beijing and Shanghai. The company specializes in developing and producing innovative drugs for various diseases. It invests significant resources in research and development, collaborating with renowned research institutes and universities. Hansoh has a wide range of products in areas such as oncology, anesthesia, antibiotics, anti-infectives, and cardiovascular diseases. It has expanded its research and development activities in recent years and has partnerships with other pharmaceutical companies. The company mainly sells its products to hospitals and medical facilities in China. It is committed to strong corporate governance and sustainability, and it has been recognized for its environmental initiatives. Overall, Hansoh Pharmaceutical Group Co Ltd is a major player in the Chinese pharmaceutical industry. Hansoh Pharmaceutical Group Company ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Hansoh Pharmaceutical Group Company's Liabilities

Hansoh Pharmaceutical Group Company's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Hansoh Pharmaceutical Group Company's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Hansoh Pharmaceutical Group Company's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Hansoh Pharmaceutical Group Company's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Hansoh Pharmaceutical Group Company’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Hansoh Pharmaceutical Group Company stock

What is the level of liabilities of Hansoh Pharmaceutical Group Company this year?

Hansoh Pharmaceutical Group Company has a debt balance of 7.24 B CNY this year.

What were the liabilities of Hansoh Pharmaceutical Group Company compared to the previous year?

The liabilities of Hansoh Pharmaceutical Group Company have increased by -1.5% dropped compared to the previous year.

What are the consequences of high debt for investors of Hansoh Pharmaceutical Group Company?

High liabilities can pose a risk for investors of Hansoh Pharmaceutical Group Company, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Hansoh Pharmaceutical Group Company?

Low liabilities mean that Hansoh Pharmaceutical Group Company has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Hansoh Pharmaceutical Group Company affect the company?

An increase in liabilities of Hansoh Pharmaceutical Group Company can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Hansoh Pharmaceutical Group Company affect the company?

A decrease in the liabilities of Hansoh Pharmaceutical Group Company can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Hansoh Pharmaceutical Group Company?

Some factors that can influence the liabilities of Hansoh Pharmaceutical Group Company include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Hansoh Pharmaceutical Group Company so important for investors?

The liabilities of Hansoh Pharmaceutical Group Company are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Hansoh Pharmaceutical Group Company take to modify the liabilities?

To change its liabilities, Hansoh Pharmaceutical Group Company can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Hansoh Pharmaceutical Group Company pay?

Over the past 12 months, Hansoh Pharmaceutical Group Company paid a dividend of 0.19 CNY . This corresponds to a dividend yield of about 1.01 %. For the coming 12 months, Hansoh Pharmaceutical Group Company is expected to pay a dividend of 0.2 CNY.

What is the dividend yield of Hansoh Pharmaceutical Group Company?

The current dividend yield of Hansoh Pharmaceutical Group Company is 1.01 %.

When does Hansoh Pharmaceutical Group Company pay dividends?

Hansoh Pharmaceutical Group Company pays a quarterly dividend. This is distributed in the months of October, July, October, July.

How secure is the dividend of Hansoh Pharmaceutical Group Company?

Hansoh Pharmaceutical Group Company paid dividends every year for the past 0 years.

What is the dividend of Hansoh Pharmaceutical Group Company?

For the upcoming 12 months, dividends amounting to 0.2 CNY are expected. This corresponds to a dividend yield of 1.08 %.

In which sector is Hansoh Pharmaceutical Group Company located?

Hansoh Pharmaceutical Group Company is assigned to the 'Health' sector.

Wann musste ich die Aktien von Hansoh Pharmaceutical Group Company kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Hansoh Pharmaceutical Group Company from 7/17/2024 amounting to 0.142 CNY, you needed to have the stock in your portfolio before the ex-date on 6/19/2024.

When did Hansoh Pharmaceutical Group Company pay the last dividend?

The last dividend was paid out on 7/17/2024.

What was the dividend of Hansoh Pharmaceutical Group Company in the year 2023?

In the year 2023, Hansoh Pharmaceutical Group Company distributed 0.23 CNY as dividends.

In which currency does Hansoh Pharmaceutical Group Company pay out the dividend?

The dividends of Hansoh Pharmaceutical Group Company are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Hansoh Pharmaceutical Group Company

Our stock analysis for Hansoh Pharmaceutical Group Company Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hansoh Pharmaceutical Group Company Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.